2022 Life Sciences Tech Trends - The Metaverse Continuum for Biopharma R&D
Update: 2022-11-11
Description
In this episode, Tom Lehmann talks with Accenture’s Ross Wooddisse, Managing Director and Life Sciences R&D Lead in Europe, about the 2022 Life Sciences Technology Vision and what the Metaverse continuum means for Biopharma R&D. They discuss how science turns into medicine, a new generation of digital trial capabilities and the fundamental opportunity for the industry to move from disease management towards risk prediction and disease prevention.
Comments
In Channel
Download from Google Play
Download from App Store
United States00:00
00:00
1.0x
